Modern Chinese Medicine Group Co., Ltd. (HKG:1643)

HKG:1643 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	799	225	204	330	492	-
Market Cap Growth	270.00%	10.29%	-38.18%	-32.93%	-	-
Enterprise Value	489	-40	-100	70	283	-
Last Close Price	1.11	0.38	0.34	0.55	0.80	-
PE Ratio	32.03	21.87	3.80	3.32	4.90	-
PS Ratio	3.61	0.99	0.54	0.73	1.11	-
PB Ratio	1.50	0.44	0.39	0.69	1.19	-
P/TBV Ratio	1.50	0.44	0.39	0.69	1.19	-
P/FCF Ratio	19.47	-	54.82	2.56	-	-
P/OCF Ratio	15.31	3.59	21.85	2.32	6.96	-
EV/Sales Ratio	2.21	-	-	0.16	0.64	-
EV/EBITDA Ratio	13.29	-	-	0.46	1.99	-
EV/EBIT Ratio	20.50	-	-	0.48	2.03	-
EV/FCF Ratio	11.91	-	-	0.55	-	-
Debt / Equity Ratio	0	0	0	0.00	0.00	0.04
Debt / EBITDA Ratio	0.00	0.00	0.00	0.00	0.00	0.05
Debt / FCF Ratio	0.00	-	0.02	0.00	-	0.13
Net Debt / Equity Ratio	-0.58	-0.47	-0.60	-0.67	-0.52	-0.50
Net Debt / EBITDA Ratio	-8.46	-6.98	-3.85	-2.10	-1.52	-0.64
Net Debt / FCF Ratio	-7.56	4.15	-84.72	-2.47	14.19	-1.60
Asset Turnover	0.39	0.40	0.67	0.89	1.19	1.86
Inventory Turnover	5.89	4.13	5.45	4.57	4.37	4.59
Quick Ratio	7.74	6.52	7.96	4.91	4.23	2.03
Current Ratio	8.53	7.20	8.93	5.49	5.24	2.55
Return on Equity (ROE)	3.99%	2.02%	10.89%	23.10%	34.64%	62.43%
Return on Assets (ROA)	2.64%	2.79%	8.30%	17.98%	23.47%	39.37%
Return on Invested Capital (ROIC)	9.04%	7.05%	29.80%	60.25%	71.10%	133.20%
Return on Capital Employed (ROCE)	4.40%	4.80%	14.30%	30.10%	33.70%	77.50%
Earnings Yield	2.60%	4.57%	26.35%	30.09%	20.40%	-
FCF Yield	5.14%	-26.16%	1.82%	39.07%	-3.09%	-
Dividend Yield	-	-	-	-	2.10%	-
Payout Ratio	-	-	-	9.47%	-	-
Buyback Yield / Dilution	-	-	-	-1.04%	-31.96%	-
Total Shareholder Return	-	-	-	-1.04%	-29.87%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.